Atlas Trials

Study of PlasmaCap IG in Adults and Children With PIDD

Clinical trial NCT03238079 · COMPLETED

Trial details

NCT number
NCT03238079
Sponsor
Evolve Biologics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Immune Deficiency Diseases (PIDD)
Start date
2017-09-05
Primary completion
2020-08-25
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.